Vascular Discovery 2026 Scientific Sessions  /  13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis  /  Rethinking Lp(a) Metabolism: Do Extracellular Vesicles Shape Its Fate?
Logo

American Heart Association

  28
  0

Final ID:

Rethinking Lp(a) Metabolism: Do Extracellular Vesicles Shape Its Fate?

  • Reyes-soffer, Gissette  ( Columbia University Medical Center , New York , New York , United States )
    • Author Disclosures:
    Gissette Reyes-Soffer: DO have relevant financial relationships ; Consultant:Eli Lilly, Inc:Active (exists now) ; Consultant:Argenex:Active (exists now) ; Advisor:Novartis :Past (completed) ; Research Funding (PI or named investigator):Kaneka, Inc:Active (exists now) ; Consultant:Merck, Inc:Active (exists now)
Meeting Info:

Vascular Discovery 2026 Scientific Sessions

2026

Bellevue, Washington

Session Info:

13. Concurrent Session 4a: Lipid Metabolism and Novel Therapeutic Targets in Atherosclerosis

Friday, 05/15/2026 , 03:30PM - 05:00PM

Oral

More abstracts on this topic:
Lipoprotein(a) undergoes Endothelial Transcytosis via Activin receptor-Like Kinase 1: An Unexpected Mechanism for Residual Cardiovascular Risk

Henry Andria, Wang Ruoqi, Liu Yitong, Yee Ho Man Ryan, Fidora Sarah, Boffa Michael, Koschinsky Marlys, Wang Changsen, Lee Warren

PIP2 metabolism as a novel therapeutic target for reverse cholesterol transport and atherosclerosis.

Gulshan Kailash, Khan Mariam

More abstracts from these authors:
Implementing Ancestry-Aware Genetics in the Clinic: The Example of LPA

Reyes-soffer Gissette, Byambaa Enkhmaa, Berglund Lars

Lp(a) - A prevalent risk factor for cardiovascular disease

Reyes-soffer Gissette

You have to be authorized to contact abstract author. Please, Login
Not Available